Dunen
Latest round
- Series A
Last raised
- Feb 2024
Total raised
- $15M
Investors
- 2
About Dunen
Based in Hangzhou, China, and established in 2017, Dunen is a biotechnology company that focuses on the precision medicine field and used the technology of gene testing. The core technology team members graduated from Tsinghua University, Fudan University, Zhejiang University and other universities. It is the landing unit of Precision Medicine Research Center under Zhejiang Tsinghua Yangtze River Delta Research Institute. In 2021, the company has acquired 15 national invention patents, 3 soft writings and national high-tech enterprise qualification application. Dunen is equipped with multiple testing equipment, including fluorescence quantitative instruments PCR, sequencer, mass spectrometry equipment, and separation and analysis equipment. The company developed multiple gene testing products for precision medicine, including gene testing for cardiology drugs, gene testing for immunity inhibitor drugs, gene testing for mental disease drugs, gene testing for pain diseases, and gene testing for children's drugs. Moreover, the company provides monitoring products for immunity inhibitor drugs, antidepressant drugs, antitumor drugs, antifungal drugs, and trace elements. Dunen also provides integrated service platforms such as new drug R&D CRO services and clinical precision drug platforms. Dunen will focus on the research and development of products and reagents related to precision medication, the strengthening of research service capacity and the market expansion of the co-laboratory.
Who invested in Dunen
2 investors across 2 rounds
See all investors in Dunen
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Dunen
Who invested in Dunen?
Dunen has 2 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Dunen raised?
Dunen has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Dunen last raise money?
Dunen's most recent round on record is a Series A, in Feb 2024.
What does Dunen do?
Based in Hangzhou, China, and established in 2017, Dunen is a biotechnology company that focuses on the precision medicine field and used the technology of gene testing.
Where is Dunen headquartered?
Dunen is headquartered in Hangzhou, China.
Which VCs invest in companies like Dunen?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, Taibao Capital and Hengxu Capital back healthcare companies at Dunen's stage. Their profiles are linked below.
VCs backing healthcare startups at Series A
Raising like Dunen? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.